Correlation Between Biodexa Pharmaceticals and MEDIFAST INC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biodexa Pharmaceticals and MEDIFAST INC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biodexa Pharmaceticals and MEDIFAST INC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biodexa Pharmaceticals and MEDIFAST INC, you can compare the effects of market volatilities on Biodexa Pharmaceticals and MEDIFAST INC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biodexa Pharmaceticals with a short position of MEDIFAST INC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biodexa Pharmaceticals and MEDIFAST INC.

Diversification Opportunities for Biodexa Pharmaceticals and MEDIFAST INC

0.07
  Correlation Coefficient

Significant diversification

The 3 months correlation between Biodexa and MEDIFAST is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Biodexa Pharmaceticals and MEDIFAST INC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MEDIFAST INC and Biodexa Pharmaceticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biodexa Pharmaceticals are associated (or correlated) with MEDIFAST INC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MEDIFAST INC has no effect on the direction of Biodexa Pharmaceticals i.e., Biodexa Pharmaceticals and MEDIFAST INC go up and down completely randomly.

Pair Corralation between Biodexa Pharmaceticals and MEDIFAST INC

Given the investment horizon of 90 days Biodexa Pharmaceticals is expected to generate 1.93 times more return on investment than MEDIFAST INC. However, Biodexa Pharmaceticals is 1.93 times more volatile than MEDIFAST INC. It trades about -0.06 of its potential returns per unit of risk. MEDIFAST INC is currently generating about -0.55 per unit of risk. If you would invest  468.00  in Biodexa Pharmaceticals on October 11, 2024 and sell it today you would lose (41.00) from holding Biodexa Pharmaceticals or give up 8.76% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Biodexa Pharmaceticals  vs.  MEDIFAST INC

 Performance 
       Timeline  
Biodexa Pharmaceticals 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Biodexa Pharmaceticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Biodexa Pharmaceticals showed solid returns over the last few months and may actually be approaching a breakup point.
MEDIFAST INC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MEDIFAST INC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Biodexa Pharmaceticals and MEDIFAST INC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biodexa Pharmaceticals and MEDIFAST INC

The main advantage of trading using opposite Biodexa Pharmaceticals and MEDIFAST INC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biodexa Pharmaceticals position performs unexpectedly, MEDIFAST INC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MEDIFAST INC will offset losses from the drop in MEDIFAST INC's long position.
The idea behind Biodexa Pharmaceticals and MEDIFAST INC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Equity Valuation
Check real value of public entities based on technical and fundamental data